Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Frost

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Medical and Pediatric Oncology|April 30, 2002
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative studyB-M Frost, S Eksborg, O Björk, et al.
Leukemia|July 11, 2008
Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroidsG Lönnerholm, A Nordgren, B-M Frost, et al.
Leukemia|November 5, 2004
Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemiaB M Frost, E Forestier, G Gustafsson, et al.
British Journal of Haematology|April 9, 2005
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineageJ Palle, B M Frost, E Forestier, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 4, 2003
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescentsB M Frost, G Lönnerholm, P Koopmans, et al.
Bone Marrow Transplantation|May 26, 2010
Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapseJ Rubin, K Vettenranta, J Vettenranta, et al.
Leukemia|October 3, 2002
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92T M Calero Moreno, G Gustafsson, S Garwicz, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Medical and Pediatric Oncology|April 30, 2002
Pharmacokinetics of doxorubicin in children with acute lymphoblastic leukemia: multi-institutional collaborative studyB-M Frost, S Eksborg, O Björk, et al.
Leukemia|July 11, 2008
Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroidsG Lönnerholm, A Nordgren, B-M Frost, et al.
Leukemia|November 5, 2004
Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemiaB M Frost, E Forestier, G Gustafsson, et al.
British Journal of Haematology|April 9, 2005
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineageJ Palle, B M Frost, E Forestier, et al.
Acta Paediatrica (Oslo, Norway : 1992)|July 4, 2003
Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescentsB M Frost, G Lönnerholm, P Koopmans, et al.
Bone Marrow Transplantation|May 26, 2010
Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapseJ Rubin, K Vettenranta, J Vettenranta, et al.
Leukemia|October 3, 2002
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92T M Calero Moreno, G Gustafsson, S Garwicz, et al.
Pageof 3